Blackstone, GSO Lead $2B Financial Package for Alnylam Pharmaceuticals
Blackstone Life Sciences and GSO Capital Partners led a $2 billion financial collaboration in support of Alnylam Pharmaceuticals. The deal includes an up to $750 million first lien senior secured term loan led by GSO.
April 14, 2020
Alnylam Pharmaceuticals | BioMed Realty | Blackstone | Blackstone Life Sciences | Blackstone Real Estate | Dwight Scott | Evercore | Goodwin Procter | GSO Capital Partners | John Maraganore | Nicholas Galakatos | Ropes & Gray and Wilkie
Phil Neuffer